| Evidence that the angiotensin IV (AT4) receptor is the enzyme insulin-regulated aminopeptidase AL Albiston, SG McDowall, D Matsacos, P Sim, E Clune, T Mustafa, J Lee, ... Journal of Biological Chemistry 276 (52), 48623-48626, 2001 | 599 | 2001 |
| Sex: a significant risk factor for neurodevelopmental and neurodegenerative disorders P Pinares-Garcia, M Stratikopoulos, A Zagato, H Loke, J Lee Brain sciences 8 (8), 154, 2018 | 167 | 2018 |
| Biological factors underlying sex differences in neurological disorders H Loke, V Harley, J Lee The international journal of biochemistry & cell biology 65, 139-150, 2015 | 155 | 2015 |
| Effect of ICV injection of AT4 receptor ligands, NLE1-angiotensin IV and LVV-hemorphin 7, on spatial learning in rats J Lee, AL Albiston, AM Allen, FAO Mendelsohn, SE Ping, GL Barrett, ... Neuroscience 124 (2), 341-349, 2004 | 153 | 2004 |
| Levodopa-induced dyskinesia in Parkinson’s disease JM Brotchie, J Lee, K Venderova Journal of neural transmission 112, 359-391, 2005 | 151 | 2005 |
| Potentiation of cholinergic transmission in the rat hippocampus by angiotensin IV and LVV-hemorphin-7 J Lee, SY Chai, FAO Mendelsohn, MJ Morris, AM Allen Neuropharmacology 40 (4), 618-623, 2001 | 135 | 2001 |
| Distribution of angiotensin IV binding sites (AT4 receptor) in the human forebrain, midbrain and pons as visualised by in vitro receptor autoradiography SY Chai, MA Bastias, EF Clune, DJ Matsacos, T Mustafa, JH Lee, ... Journal of chemical neuroanatomy 20 (3-4), 339-348, 2000 | 119 | 2000 |
| AT4 receptor is insulin-regulated membrane aminopeptidase: potential mechanisms of memory enhancement AL Albiston, T Mustafa, SG McDowall, FAO Mendelsohn, J Lee, SY Chai Trends in Endocrinology & Metabolism 14 (2), 72-77, 2003 | 117 | 2003 |
| Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia J Lee, WM Zhu, D Stanic, DI Finkelstein, MH Horne, J Henderson, ... Brain 131 (6), 1574-1587, 2008 | 111 | 2008 |
| The human testis‐determining factor SRY localizes in midbrain dopamine neurons and regulates multiple components of catecholamine synthesis and metabolism DP Czech, J Lee, H Sim, CL Parish, E Vilain, VR Harley Journal of neurochemistry 122 (2), 260-271, 2012 | 105 | 2012 |
| A role for vanilloid receptor 1 (TRPV1) and endocannabinnoid signalling in the regulation of spontaneous and L-DOPA induced locomotion in normal and reserpine-treated rats J Lee, V Di Marzo, JM Brotchie Neuropharmacology 51 (3), 557-565, 2006 | 90 | 2006 |
| Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase J Lee, T Mustafa, SG McDowall, FAO Mendelsohn, M Brennan, RA Lew, ... Journal of Pharmacology and Experimental Therapeutics 305 (1), 205-211, 2003 | 87 | 2003 |
| Sex-specific neuroprotection by inhibition of the Y-chromosome gene, SRY, in experimental Parkinson’s disease J Lee, P Pinares-Garcia, H Loke, S Ham, E Vilain, VR Harley Proceedings of the National Academy of Sciences 116 (33), 16577-16582, 2019 | 77 | 2019 |
| The male fight‐flight response: A result of SRY regulation of catecholamines? J Lee, VR Harley BioEssays 34 (6), 454-457, 2012 | 60 | 2012 |
| Bioactive angiotensin peptides: focus on angiotensin IV T Mustafa, JH Lee, SY Chai, AL Albiston, SG McDowall, FAO Mendelsohn Journal of the Renin-Angiotensin-Aldosterone System 2 (4), 205-210, 2001 | 57 | 2001 |
| Modulation of neuropeptide Y overflow by leptin in the rat hypothalamus, cerebral cortex and medulla J Lee, MJ Morris Neuroreport 9 (7), 1575-1580, 1998 | 40 | 1998 |
| A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease TH Johnston, J Lee, J Gomez-Ramirez, SH Fox, JM Brotchie Experimental neurology 191 (2), 243-250, 2005 | 38 | 2005 |
| Transient neuroprotection by SRY upregulation in dopamine cells following injury in males DP Czech, J Lee, J Correia, H Loke, EK Möller, VR Harley Endocrinology 155 (7), 2602-2612, 2014 | 31 | 2014 |
| Human umbilical cord therapy improves long-term behavioral outcomes following neonatal hypoxic ischemic brain injury TR Penny, AE Sutherland, JG Mihelakis, MCB Paton, Y Pham, J Lee, ... Frontiers in physiology 10, 283, 2019 | 29 | 2019 |
| Chronic cocaine administration reduces striatal dopamine terminal density and striatal dopamine release which leads to drug-seeking behaviour J Lee, CL Parish, D Tomas, MK Horne Neuroscience 174, 143-150, 2011 | 28 | 2011 |
Frederick MendelsohnFlorey institute在 unimelb.edu.au 的电子邮件经过验证
